Currently, I am involved in developing high-throughput bioinformatics genomic pipelines that will be used to monitor food and clinical outbreaks.

While at the Broad Institute, I was involved in the development, management, and analysis of comparative bacterial genomics projects at the Broad Institute, including those funded by the NIAID-funded Genome Sequencing Center for Infectious Diseases. Projects included the sequencing of ~100 E. coli commensal isolates to better understand the evolution of antibiotic resistance and virulence and of 40 isolates of the MRSA USA200 clone to determine the factors involved with epidemic spread of resistant organisms. Previous work has included analysis of the microbiome as part of the Human Microbiome Project consortium.

While at APUA, I conducted NIH-funded research and oversaw multiple projects funded by APUA, as well as engaged in public policy, both in the areas of drug use and drug development

While at Stony Brook University, I examined the biological basis of urinary tract infections with goal to identify therapeutic targets by using DNA sequence and statistical analysis to develop tools to identify genes responsible for disease.